Cargando…

Genotype‐specific pathogenic effects in human dilated cardiomyopathy

KEY POINTS: Mutations in genes encoding cardiac troponin I (TNNI3) and cardiac troponin T (TNNT2) caused altered troponin protein stoichiometry in patients with dilated cardiomyopathy. TNNI3(p.98trunc) resulted in haploinsufficiency, increased Ca(2+)‐sensitivity and reduced length‐dependent activati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bollen, Ilse A. E., Schuldt, Maike, Harakalova, Magdalena, Vink, Aryan, Asselbergs, Folkert W., Pinto, Jose R., Krüger, Martina, Kuster, Diederik W. D., van der Velden, Jolanda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Cardiovascular
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5509872/ https://www.ncbi.nlm.nih.gov/pubmed/28436080 http://dx.doi.org/10.1113/JP274145

Ejemplares similares

Peripartum cardiomyopathy and dilated cardiomyopathy: different at heart
por: Bollen, Ilse A. E., et al.
Publicado: (2015)

End‐diastolic force pre‐activates cardiomyocytes and determines contractile force: role of titin and calcium
por: Najafi, Aref, et al.
Publicado: (2019)

Sex-Related Differences in Protein Expression in Sarcomere Mutation-Positive Hypertrophic Cardiomyopathy
por: Schuldt, Maike, et al.
Publicado: (2021)

Genetic Basis of Dilated Cardiomyopathy in Dogs and Its Potential as a Bidirectional Model
por: Gaar-Humphreys, Karen R., et al.
Publicado: (2022)

Targeting lipid metabolism as a new therapeutic strategy for inherited cardiomyopathies
por: Gaar-Humphreys, Karen R., et al.
Publicado: (2023)

Proteomic and Functional Studies Reveal Detyrosinated Tubulin as Treatment Target in Sarcomere Mutation-Induced Hypertrophic Cardiomyopathy
por: Schuldt, Maike, et al.
Publicado: (2021)

Mutation location of HCM-causing troponin T mutations defines the degree of myofilament dysfunction in human cardiomyocytes
por: Schuldt, Maike, et al.
Publicado: (2021)

Untying the knot: protein quality control in inherited cardiomyopathies
por: Dorsch, Larissa M., et al.
Publicado: (2018)

Cardiomyocyte Hypocontractility and Reduced Myofibril Density in End-Stage Pediatric Cardiomyopathy
por: Bollen, Ilse A. E., et al.
Publicado: (2017)

Cardiovascular genetics: technological advancements and applicability for dilated cardiomyopathy
por: Kummeling, G.J.M., et al.
Publicado: (2015)

Unraveling the Genotype‐Phenotype Relationship in Hypertrophic Cardiomyopathy: Obesity‐Related Cardiac Defects as a Major Disease Modifier
por: Nollet, Edgar E., et al.
Publicado: (2020)

Protein Quality Control Activation and Microtubule Remodeling in Hypertrophic Cardiomyopathy
por: Dorsch, Larissa M., et al.
Publicado: (2019)

Shared Genetic Etiology of Primary Dilated Cardiomyopathy and Ischemic Dilated Cardiomyopathy
por: Sun, Yang, et al.
Publicado: (2021)

P62‐positive aggregates are homogenously distributed in the myocardium and associated with the type of mutation in genetic cardiomyopathy
por: van der Klooster, Zoë Joy, et al.
Publicado: (2021)

Sex-specific cardiac remodeling in early and advanced stages of hypertrophic cardiomyopathy
por: Nijenkamp, Louise L. A. M., et al.
Publicado: (2020)

Diagnosis and Risk Prediction of Dilated Cardiomyopathy in the Era of Big Data and Genomics
por: Sammani, Arjan, et al.
Publicado: (2021)

Scientists on the spot: Relaxing the heart in hypertrophic cardiomyopathy
por: Gladka, Monika M, et al.
Publicado: (2023)

A multifactorial aetiology for dilated cardiomyopathy
por: Herrera Flores, Cristian, et al.
Publicado: (2021)

High Resolution Systematic Digital Histological Quantification of Cardiac Fibrosis and Adipose Tissue in Phospholamban p.Arg14del Mutation Associated Cardiomyopathy
por: Gho, Johannes M. I. H., et al.
Publicado: (2014)

Early-stage alcohol-induced cardiomyopathy: not so much dilatation and dysfunction
por: Carrillo-Bailen, Magdalena, et al.
Publicado: (2023)

Plasma Metabolomic Profiles Differentiate Patients With Dilated Cardiomyopathy and Ischemic Cardiomyopathy
por: Zhao, Junhan, et al.
Publicado: (2020)

The Genetic Pathways Underlying Immunotherapy in Dilated Cardiomyopathy
por: Kadhi, Ayat, et al.
Publicado: (2021)

Precision and genomic medicine for dilated and hypertrophic cardiomyopathy
por: Nomura, Seitaro, et al.
Publicado: (2023)

The first titin (c.59926 + 1G > A) founder mutation associated with dilated cardiomyopathy
por: Hoorntje, Edgar T., et al.
Publicado: (2017)

Sex and gender differences in myocarditis and dilated cardiomyopathy: An update
por: Fairweather, DeLisa, et al.
Publicado: (2023)

Risk Factors and Prevalence of Dilated Cardiomyopathy in Sub-Saharan Africa: Protocol for a Systematic Review
por: Fundikira, Lulu Said, et al.
Publicado: (2021)

Outcomes of Spironolactone Withdrawal in Dilated Cardiomyopathy With Improved Ejection Fraction
por: Chen, Yanjia, et al.
Publicado: (2021)

Changes in the Left Ventricular Eicosanoid Profile in Human Dilated Cardiomyopathy
por: Sosnowski, Deanna K., et al.
Publicado: (2022)

Identification of Heparan Sulfate in Dilated Cardiomyopathy by Integrated Bioinformatics Analysis
por: Song, Wenyu, et al.
Publicado: (2022)

DILATED CARDIOMYOPATHY WITH CARDIOGENIC SHOCK SECONDARY TO COVID-19 INFECTION
por: RICHARDSON, AUSTIN, et al.
Publicado: (2022)

Extensive Association of Common Disease Variants with Regulatory Sequence
por: Mokry, Michal, et al.
Publicado: (2016)

Strength of patient cohorts and biobanks for cardiomyopathy research
por: de Boer, R. A., et al.
Publicado: (2020)

Identification of novel genetic risk factors of dilated cardiomyopathy: from canine to human
por: Niskanen, Julia E., et al.
Publicado: (2023)

Exploring Key Genes to Construct a Diagnosis Model of Dilated Cardiomyopathy
por: Zheng, Youyang, et al.
Publicado: (2022)

Metabolomics Fingerprint Predicts Risk of Death in Dilated Cardiomyopathy and Heart Failure
por: Vignoli, Alessia, et al.
Publicado: (2022)

Development and validation of nomogram for unplanned ICU admission in patients with dilated cardiomyopathy
por: Li, Xiao-Lei, et al.
Publicado: (2023)

Radiomics-Based Classification of Left Ventricular Non-compaction, Hypertrophic Cardiomyopathy, and Dilated Cardiomyopathy in Cardiovascular Magnetic Resonance
por: Izquierdo, Cristian, et al.
Publicado: (2021)

High reproducibility of adenosine stress cardiac MR myocardial perfusion imaging in patients with non-ischaemic dilated cardiomyopathy
por: Lawson, Mark A, et al.
Publicado: (2014)

Differences between familial and sporadic dilated cardiomyopathy: ESC EORP Cardiomyopathy & Myocarditis registry
por: Asselbergs, Folkert W., et al.
Publicado: (2020)

Integrative Bioinformatics Approaches for Identification of Drug Targets in Hypertension
por: Hemerich, Daiane, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_sib0ov845lvriehh7130qi1jr9